Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition

Osteosarcoma is an uncommon tumor occurring in bone, accompanied by elevated incidence and reduced rate of healing. Epithelial‐to‐mesenchymal transition (EMT) serves as a conceptual paradigm to explain the invasion and metastasis of osteosarcoma and other cancers. Hence, developing effective therape...

Full description

Bibliographic Details
Main Authors: Wei Liu, Pengcheng Liu, Hang Gao, Xu Wang, Ming Yan
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12711
_version_ 1797776349026320384
author Wei Liu
Pengcheng Liu
Hang Gao
Xu Wang
Ming Yan
author_facet Wei Liu
Pengcheng Liu
Hang Gao
Xu Wang
Ming Yan
author_sort Wei Liu
collection DOAJ
description Osteosarcoma is an uncommon tumor occurring in bone, accompanied by elevated incidence and reduced rate of healing. Epithelial‐to‐mesenchymal transition (EMT) serves as a conceptual paradigm to explain the invasion and metastasis of osteosarcoma and other cancers. Hence, developing effective therapeutic strategy to treat the EMT of osteosarcoma is essential. Here, we identified the molecular mechanism of long noncoding RNA (lncRNA) PGM5‐AS1 in EMT and progression of osteosarcoma. Microarray‐based analysis was employed to screen the osteosarcoma‐related differentially expressed lncRNAs. The levels of PGM5‐AS1 as well as microRNA‐140‐5p (miR‐140‐5p) and fibrillin‐1 (FBN1) in osteosarcoma tissues and cells were determined. Dual‐luciferase reporter gene assay, RNA pull‐down assay, and RNA immunoprecipitation assay were conducted to validate the relationship among PGM5‐AS1, miR‐140‐5p, and FBN1. Expression of PGM5‐AS1, miR‐140‐5p, and FBN1 was altered by overexpression, shRNA, mimic, or inhibitors in order to investigate how they regulated migration, invasion, and EMT of osteosarcoma cells in vitro. Loss‐ and gain‐of‐function approaches were employed in nude mice to detect their roles in tumorigenesis in vivo. Osteosarcoma tissues and cells exhibited low expression of miR‐140‐5p, but high expression of PGM5‐AS1 and FBN1. PGM5‐AS1 competitively bound to miR‐140‐5p to upregulate FBN1. Furthermore, hindering PGM5‐AS1 and FBN1 or overexpressing miR‐140‐5p dampened migration, invasion, and EMT of osteosarcoma cells in vitro. Furthermore, silencing PGM5‐AS1 or FBN1, or overexpressing miR‐140‐5p markedly inhibited tumorigenesis in nude mice in vivo. Taken together, PGM5‐AS1 depletion causes FBN1 reduction to retard osteosarcoma processes by negatively modulating miR‐140‐5p.
first_indexed 2024-03-12T22:49:37Z
format Article
id doaj.art-f475db646a064d69b752e41867c21787
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-03-12T22:49:37Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-f475db646a064d69b752e41867c217872023-07-20T17:20:38ZengWileyMolecular Oncology1574-78911878-02612020-10-0114102660267710.1002/1878-0261.12711Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibitionWei Liu0Pengcheng Liu1Hang Gao2Xu Wang3Ming Yan4Department of Spine Surgery The First Hospital of Jilin University Changchun ChinaDepartment of Hand and Foot Surgery The First Hospital of Jilin University Changchun ChinaDepartment of Bone and Joint Surgery The First Hospital of Jilin University Changchun ChinaDepartment of Colorectal and Anal Surgery The First Hospital of Jilin University Changchun ChinaDepartment of Spine Surgery The First Hospital of Jilin University Changchun ChinaOsteosarcoma is an uncommon tumor occurring in bone, accompanied by elevated incidence and reduced rate of healing. Epithelial‐to‐mesenchymal transition (EMT) serves as a conceptual paradigm to explain the invasion and metastasis of osteosarcoma and other cancers. Hence, developing effective therapeutic strategy to treat the EMT of osteosarcoma is essential. Here, we identified the molecular mechanism of long noncoding RNA (lncRNA) PGM5‐AS1 in EMT and progression of osteosarcoma. Microarray‐based analysis was employed to screen the osteosarcoma‐related differentially expressed lncRNAs. The levels of PGM5‐AS1 as well as microRNA‐140‐5p (miR‐140‐5p) and fibrillin‐1 (FBN1) in osteosarcoma tissues and cells were determined. Dual‐luciferase reporter gene assay, RNA pull‐down assay, and RNA immunoprecipitation assay were conducted to validate the relationship among PGM5‐AS1, miR‐140‐5p, and FBN1. Expression of PGM5‐AS1, miR‐140‐5p, and FBN1 was altered by overexpression, shRNA, mimic, or inhibitors in order to investigate how they regulated migration, invasion, and EMT of osteosarcoma cells in vitro. Loss‐ and gain‐of‐function approaches were employed in nude mice to detect their roles in tumorigenesis in vivo. Osteosarcoma tissues and cells exhibited low expression of miR‐140‐5p, but high expression of PGM5‐AS1 and FBN1. PGM5‐AS1 competitively bound to miR‐140‐5p to upregulate FBN1. Furthermore, hindering PGM5‐AS1 and FBN1 or overexpressing miR‐140‐5p dampened migration, invasion, and EMT of osteosarcoma cells in vitro. Furthermore, silencing PGM5‐AS1 or FBN1, or overexpressing miR‐140‐5p markedly inhibited tumorigenesis in nude mice in vivo. Taken together, PGM5‐AS1 depletion causes FBN1 reduction to retard osteosarcoma processes by negatively modulating miR‐140‐5p.https://doi.org/10.1002/1878-0261.12711fibrillin‐1long noncoding RNA PGM5‐AS1microRNA‐140‐5posteosarcoma
spellingShingle Wei Liu
Pengcheng Liu
Hang Gao
Xu Wang
Ming Yan
Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
Molecular Oncology
fibrillin‐1
long noncoding RNA PGM5‐AS1
microRNA‐140‐5p
osteosarcoma
title Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
title_full Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
title_fullStr Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
title_full_unstemmed Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
title_short Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
title_sort retracted long non coding rna pgm5 as1 promotes epithelial mesenchymal transition invasion and metastasis of osteosarcoma cells by impairing mir 140 5p mediated fbn1 inhibition
topic fibrillin‐1
long noncoding RNA PGM5‐AS1
microRNA‐140‐5p
osteosarcoma
url https://doi.org/10.1002/1878-0261.12711
work_keys_str_mv AT weiliu retractedlongnoncodingrnapgm5as1promotesepithelialmesenchymaltransitioninvasionandmetastasisofosteosarcomacellsbyimpairingmir1405pmediatedfbn1inhibition
AT pengchengliu retractedlongnoncodingrnapgm5as1promotesepithelialmesenchymaltransitioninvasionandmetastasisofosteosarcomacellsbyimpairingmir1405pmediatedfbn1inhibition
AT hanggao retractedlongnoncodingrnapgm5as1promotesepithelialmesenchymaltransitioninvasionandmetastasisofosteosarcomacellsbyimpairingmir1405pmediatedfbn1inhibition
AT xuwang retractedlongnoncodingrnapgm5as1promotesepithelialmesenchymaltransitioninvasionandmetastasisofosteosarcomacellsbyimpairingmir1405pmediatedfbn1inhibition
AT mingyan retractedlongnoncodingrnapgm5as1promotesepithelialmesenchymaltransitioninvasionandmetastasisofosteosarcomacellsbyimpairingmir1405pmediatedfbn1inhibition